Search
Cryo-Cell International Inc
CCELAdd to Watchlist
3.220USD
+0.030+0.94%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
25.94MMarket Cap
LossP/E TTM
More Details of Cryo-Cell International Inc Company
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Cryo-Cell International Inc Info
Ticker SymbolCCEL
Company nameCryo-Cell International Inc
IPO dateApr 04, 1994
CEOPortnoy (Mark L)
Number of employees82
Security typeOrdinary Share
Fiscal year-endApr 04
Address700 Brooker Creek Blvd
CityOLDSMAR
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code34677
Phone18137492104
Websitehttps://www.cryo-cell.com/
Ticker SymbolCCEL
IPO dateApr 04, 1994
CEOPortnoy (Mark L)
Company Executives of Cryo-Cell International Inc
Name
Name/Position
Position
Shareholding
Change
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.70M
+0.92%
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
--
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
52.90K
+14.18%
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Mr. Mark L. Portnoy
Mr. Mark L. Portnoy
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--
Ms. Irene Smith
Ms. Irene Smith
Executive Assistant / Office Manager
Executive Assistant / Office Manager
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.70M
+0.92%
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
--
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
52.90K
+14.18%
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Mr. Mark L. Portnoy
Mr. Mark L. Portnoy
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--
FAQs
Who are the top five shareholders of Cryo-Cell International Inc?
The top five shareholders of Cryo-Cell International Inc are: Mr. David I. Portnoy
How many institutions hold shares of Cryo-Cell International Inc (CCEL)?
As of 2026Q1, 36 institutions hold shares of Cryo-Cell International Inc, with a combined market value of approximately 1.00M, accounting for 12.47% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -82390.00.
What is the biggest source of revenue for Cryo-Cell International Inc?
In 2026Q1, the Processing and storage fees business generated the highest revenue for Cryo-Cell International Inc, amounting to 31.38M and accounting for 99.42% of total revenue.